AbbVie invests $217 million to modernize Puerto Rico manufacturing campus
ABBV•AbbVie will invest $217 million to modernize its biologics manufacturing campus in Barceloneta, Puerto Rico, with work beginning in 2026 and full operations expected by 2030. The project is expected to create 100 jobs and is part of a $100 billion U.S. research and development and capital investment commitment over the next decade.
1. Campus modernization
AbbVie will modernize its biologics manufacturing campus in Barceloneta, Puerto Rico, integrating advanced manufacturing technologies with artificial intelligence to support current and next-generation immunology and neuroscience medicines. Work is scheduled to begin in 2026, with full operations expected by 2030; the project is expected to create 100 jobs.




